Business
Join AIML's Live Shareholder Update with Chairman & CEO Paul Duffy
A Look Back at Key Milestones and Successes Achieved in 2025 What's Ahead: Exciting Plans, Strategic Outlook, and Goals for 2026 Advancing the Next Phase of Commercialization TORONTO, ON / ACCESS Newswire / December 16, 2025 / AI/ML Innovations Inc. ...
About this update from Aiml Innovations Inc
[{"type":"list","items":[{"val":[{"type":"text","content":"A Look Back at Key Milestones and Successes Achieved in 2025","length":60,"tagName":"p"}]},{"val":[{"type":"text","content":"What's Ahead: Exciting Plans, Strategic Outlook, and Goals for 2026","length":71,"tagName":"p"}]},{"val":[{"type":"text","content":"Advancing the Next Phase of Commercialization","length":45,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":176,"olType":false},{"type":"text","content":"TORONTO, ON / ACCESS Newswire / December 16, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to invite shareholders and stakeholders to join an upcoming Livestream Company Update, hosted by Chairman and CEO Paul Duffy.","length":291,"tagName":"p"},{"type":"text","content":"The livestream event will provide an overview of AIML's key achievements from 2025, along with a preview of exciting milestones planned for the first 90 days of 2026. Shareholders will have the opportunity to hear firsthand how AIML is executing on its commercialization strategy and driving growth across its portfolio of AI-powered healthcare technologies.","length":362,"tagName":"p"},{"type":"text","content":"Event Details:","length":14,"tagName":"p"},{"type":"text","content":"Date: Thursday, December 18, 2025Time: 4pm Eastern Standard TimeAccess Link: Zoom Link","length":88,"tagName":"p"},{"type":"text","content":""We've had a strong 2025 that marked the beginning of commercialization through several pilot programs, and we're encouraged by the progress we've made," said Chairman and CEO, Paul Duffy. "As we look ahead to 2026, our focus is on continuing to aggressively pursue further commercialization while advancing our regulatory approval pathways. This livestream is an opportunity to connect with our shareholders around our vision, our execution strategy, and the important work we're doing to bring AI-driven health innovation to market.","length":565,"tagName":"p"},{"type":"text","content":"Shareholders are encouraged to attend and participate in this interactive session to gain deeper insight into AIML's trajectory and future opportunities. If you would like to pre-submit questions as part of the livestream, please email them to [email protected].","length":264,"tagName":"p"},{"type":"text","cont...